Allison Karen, Hodges Brittany, Shahid Mohammed Mehdi, Feng Changyong
Flaum Eye Institute, University of Rochester, Rochester, NY 14642, USA.
Prevention of Blindness from Glaucoma and Age Related Macular Degeneration, 248 36 Jericho Turnpike, Floral Park, NY 10012, USA.
J Clin Med. 2024 Nov 28;13(23):7225. doi: 10.3390/jcm13237225.
Glaucoma is one of the leading causes of irreversible blindness around the world. Black individuals are two times more likely to be diagnosed with glaucoma compared to White individuals. In 2019, the prevalence of glaucoma in Monroe County was highest amongst older individuals aged 85 and non-Hispanic Blacks. This study seeks to explore differences in glaucoma treatment rates that may be exacerbating disease severity and prognosis for individuals most acutely affected by glaucoma in Monroe County, NY. We used data from the Center for Disease Control's National Vision and Eye Health Surveillance System (VEHSS) to assess the rates of glaucoma treatment for different racial, gender, and age demographic groups in Monroe County, NY. The source data were from individuals enrolled in Medicare who filed a claim. We stratified the data based on the glaucoma treatment type: laser glaucoma surgery, glaucoma drainage devices, other glaucoma surgery, or glaucoma prescription drugs. The main outcome variable was the prevalence rate of various types of glaucoma treatment in Monroe County, NY. The data were analyzed by potential risk covariates such as race/ethnicity, age, and gender. A descriptive data analysis was performed to assess for demographic trends. The most common form of glaucoma treatment in Monroe County, NY was prescription drug therapy (36.82%), which was predominant across all racial, gender, and age groups. This was followed by laser surgery (3.26%), glaucoma drain (1.47%), and other forms of glaucoma surgery (0.58%). Women displayed a higher incidence of laser surgery, glaucoma drainage, and other glaucoma surgeries (3.58%, 1.77%, and 0.69%, respectively) with a lower incidence of prescription drug usage (36.14%) compared to men. Black non-Hispanic patients had a higher incidence of laser surgery and prescription drug usage (3.39% and 47.20%, respectively), but a lower incidence of glaucoma drainage and other glaucoma surgeries (1% and 0%, respectively) compared to other racial groups. This study elucidates the differences in glaucoma treatment types across different racial, gender, and age groups in Monroe County, NY. The results underscore the disparities in treatment rates for Medicare patients diagnosed with glaucoma in Monroe County. The results justify the need for increased interventions to increase access to a variety of glaucoma treatment options to mitigate disparities in glaucoma outcomes.
青光眼是全球不可逆性失明的主要原因之一。与白人相比,黑人被诊断出患有青光眼的可能性高出两倍。2019年,门罗县85岁及以上的老年人和非西班牙裔黑人中青光眼的患病率最高。本研究旨在探讨青光眼治疗率的差异,这些差异可能会加剧纽约州门罗县受青光眼影响最严重的个体的疾病严重程度和预后。我们使用了疾病控制中心的国家视力与眼健康监测系统(VEHSS)的数据,来评估纽约州门罗县不同种族、性别和年龄人群的青光眼治疗率。源数据来自参加医疗保险并提交索赔申请的个人。我们根据青光眼治疗类型对数据进行分层:激光青光眼手术、青光眼引流装置、其他青光眼手术或青光眼处方药。主要结果变量是纽约州门罗县各类青光眼治疗的患病率。数据通过种族/族裔、年龄和性别等潜在风险协变量进行分析。进行了描述性数据分析以评估人口趋势。纽约州门罗县最常见的青光眼治疗形式是药物治疗(36.82%),在所有种族、性别和年龄组中都占主导地位。其次是激光手术(3.26%)、青光眼引流(1.47%)和其他形式的青光眼手术(0.58%)。与男性相比,女性接受激光手术、青光眼引流和其他青光眼手术的发生率更高(分别为3.58%、1.77%和0.69%),而使用处方药的发生率较低(36.14%)。与其他种族群体相比,非西班牙裔黑人患者接受激光手术和使用处方药的发生率较高(分别为3.39%和47.20%),但接受青光眼引流和其他青光眼手术的发生率较低(分别为1%和0%)。本研究阐明了纽约州门罗县不同种族、性别和年龄组在青光眼治疗类型上的差异。结果强调了门罗县被诊断患有青光眼的医疗保险患者在治疗率上的差异。结果表明有必要增加干预措施以增加获得各种青光眼治疗选择的机会,从而减少青光眼治疗结果的差异。